Abstract
This paper reviews the basic biology and biochemistry of the TGF-β isoforms including their unique serine-threonine receptors and signaling intermediates. Dysregulation of TGF-β expression and/or receptor/signaling function have been implicated in a wide variety of pathologies. We will discuss mechanisms underlying some of these disease processes as gained from study of transgenic mice in which expression of TGF-β1 has either been lost by targeted deletion of its gene, is overexpressed in a tissue-specific manner, or blocked by its latency associated peptide.
| Original language | English |
|---|---|
| Pages (from-to) | 1355-1360 |
| Number of pages | 6 |
| Journal | Kidney International |
| Volume | 51 |
| Issue number | 5 |
| DOIs | |
| State | Published - 1997 |
| Externally published | Yes |